The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Moretta, Lorenzo ^a,c   Pietra, Gabriella ^a   Romagnani, Chiara ^b   Manzini, Claudia ^a   Mingari, Maria Cristina ^a,d  

^a UNIVERSITY OF GENOA   (Italy)

^b German Rheumatism Research Center   (Germany)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA E ANTIGEN; T LYMPHOCYTE RECEPTOR; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA-E ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE;

ADAPTIVE IMMUNITY; CD8+ T LYMPHOCYTE; CELL FUNCTION; COLON CANCER; CYTOMEGALOVIRUS INFECTION; GLIOMA; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; LYMPHOMA; MELANOMA; NATURAL KILLER CELL; NONHUMAN; OVARY CARCINOMA; PROTEIN BINDING; REVIEW; SALMONELLA ENTERICA; IMMUNOLOGY; MYCOBACTERIOSIS; NEOPLASM; VIRUS INFECTION;

ADAPTIVE IMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MYCOBACTERIUM INFECTIONS; NEOPLASMS; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; VIRUS DISEASES;

EID: 77955378317     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/907092     Document Type: Review

References (57)

1. Bjorkman P. J., Parham P., Structure, function, and diversity of class I major histocompatibility complex molecules Annual Review of Biochemistry 1990 59 253 288
2. Rodgers J. R., Cook R. G., MHC class IB molecules bridge innate and acquired immunity Nature Reviews Immunology 2005 5 6 459 471
3. Lenfant F., Pizzato N., Liang S., Davrinche C., Le Bouteiller P., Horuzsko A., Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice Journal of General Virology 2003 84 2 307 317
4. Grimsley C., Kawasaki A., Gassner C., Sageshima N., Nose Y., Hatake K., Geraghty D. E., Ishitani A., Definitive high resolution typing of HLA-E allelic polymorphisms: identifying potential errors in existing allele data Tissue Antigens 2002 60 3 206 212
5. Ulbrecht M., Couturier A., Martinozzi S., Pla M., Srivastava R., Peterson P. A., Weiss E. H., Cell surface expression of HLA-E: interaction with human 2-microglobulin and allelic differences European Journal of Immunology 1999 29 2 537 547
6. O'Callaghan C. A., Tormo J., Willcox B. E., Braud V. M., Jakobsen B. K., Stuart D. I., McMichael A. J., Bell J. I., Jones E. Y., Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E Molecular Cell 1998 1 4 531 541
7. Lee N., Goodlett D. R., Ishitani A., Marquardt H., Geraghty D. E., HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences Journal of Immunology 1998 160 10 4951 4960
8. Bland F. A., Lemberg M. K., McMichael A. J., Martoglio B., Braud V. M., Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E Journal of Biological Chemistry 2003 278 36 33747 33752
9. Wei X., Orr H. T., Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue Human Immunology 1990 29 2 131 142
10. Braud V., Jones E. Y., McMichael A., The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9 European Journal of Immunology 1997 27 5 1164 1169
11. Mittelbronn M., Simon P., Lffler C., Capper D., Bunz B., Harter P., Schlaszus H., Schleich A., Tabatabai G., Goeppert B., Meyermann R., Weller M., Wischhusen J., Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8 + cells Journal of Neuroimmunology 2007 189 1-2 50 58
12. Derr L., Corvaisier M., Charreau B., Moreau A., Godefroy E., Moreau-Aubry A., Jotereau F., Gervois N., Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells Journal of Immunology 2006 177 5 3100 3107
13. Braud V. M., Allan D. S. J., O'Callaghan C. A., Soderstrom K., D'Andrea A., Ogg G. S., Lazetic S., Young N. T., Bell J. I., Phillips J. H., Lanler L. L., McMichael A. J., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C Nature 1998 391 6669 795 799
14. Lee N., Llano M., Carretero M. A., Navarro F., Lpez-Botet M., Geraghty D. E., HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A Proceedings of the National Academy of Sciences of the United States of America 1998 95 9 5199 5204
15. Brooks A. G., Borrego F., Posch P. E., Patamawenu A., Scorzelli C. J., Ulbrecht M., Weiss E. H., Coligan J. E., Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94FNKG2A and NK cells Journal of Immunology 1999 162 1 305 313
16. Li J., Goldstein I., Glickman-Nir E., Jiang H., Chess L., Induction of TCR V -specific CD8 + CTLs by TCR V -derived peptides bound to HLA-E Journal of Immunology 2001 167 7 3800 3808
17. Pietra G., Romagnani C., Falco M., Vitale M., Castriconi R., Pende D., Millo E., Anfossi S., Biassoni R., Moretta L., Mingari M. C., The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR / -mediated recognition European Journal of Immunology 2001 31 12 3687 3693
18. Garca P., Llano M., De Heredia A. B., Willberg C. B., Caparrs E., Aparicio P., Braud V. M., Lpez-Botet M., Human T cell receptor-mediated recognition of HLA-E European Journal of Immunology 2002 32 4 936 944
19. Heinzel A. S., Grotzke J. E., Lines R. A., Lewinsohn D. A., McNabb A. L., Streblow D. N., Brand V. M., Grieser H. J., Belisle J. T., Lewinsohn D. M., HLA-E-dependent presentation of Mtb-derived antigen to human CD8 + T cells Journal of Experimental Medicine 2002 196 11 1473 1481
20. Salerno-Gonalves R., Fernandez-Via M., Lewinsohn D. M., Sztein M. B., Identification of a human HLA-E-restricted CD8 + T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine Journal of Immunology 2004 173 9 5852 5862
21. Sullivan L. C., Clements C. S., Rossjohn J., Brooks A. G., The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity Tissue Antigens 2008 72 5 415 424
22. Tomasec P., Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40 Science 2000 287 5455 1031 1033
23. Michalsson J., Teixeira de Matos C. T., Achour A., Lanier L. L., Krre K., Sderstrm K., A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition Journal of Experimental Medicine 2002 196 11 1403 1414
24. Wooden S. L., Kalb S. R., Cotter R. J., Soloski M. J., Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis Journal of Immunology 2005 175 3 1383 1387
25. Nattermann J., Nischalke H. D., Hofmeister V., Kupfer B., Ahlenstiel G., Feldmann G., Rockstroh J., Weiss E. H., Sauerbruch T., Spengler U., HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells Antiviral Therapy 2005 10 1 95 107
26. Terrazzano G., Sica M., Gianfrani C., Mazzarella G., Maurano F., De Giulio B., De Saint-Mezard S., Zanzi D., Maiuri L., Londei M., Jabri B., Troncone R., Auricchio S., Zappacosta S., Carbone E., Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization Journal of Immunology 2007 179 1 372 381
27. Ulbrecht M., Modrow S., Srivastava R., Peterson P. A., Weiss E. H., Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation Journal of Immunology 1998 160 9 4375 4385
28. Nattermann J., Nischalke H. D., Hofmeister V., Ahlenstiel G., Zimmermann H., Leifeld L., Weiss E. H., Sauerbruch T., Spengler U., The HLA-A2 restricted T cell epitope HCV core35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells American Journal of Pathology 2005 166 2 443 453
29. Sensi M., Pietra G., Molla A., Nicolini G., Vegetti C., Bersani I., Millo E., Weiss E., Moretta L., Mingari M. C., Anichini A., Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5 International Immunology 2009 21 3 257 268
30. Rock K. L., Goldberg A. L., Degradation of cell proteins and the generation of MHC class I-presented peptides Annual Review of Immunology 1999 17 739 779
31. Posch P. E., Borrego F., Brooks A. G., Coligan J. E., HLA-E is the ligand for the natural killer cell CD94/NKG2 receptors Journal of Biomedical Science 1998 5 5 321 331
32. Lpez-Botet M., Carretero M., Belln T., Prez-Villar J. J., Llano M., Navarro F., The CD94/NKG2 C-type lectin receptor complex Current Topics in Microbiology and Immunology 1998 230 41 52
33. Mingari M. C., Vitale C., Cambiaggi A., Schiavetti F., Melioli G., Ferrini S., Poggi A., Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production International Immunology 1995 7 4 697 703
34. Mingari M. C., Schiavetti F., Ponte M., Vitale C., Maggi E., Romagnani S., Demarest J., Pantaleo G., Fauci A. S., Moretta L., Human CD8 + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations Proceedings of the National Academy of Sciences of the United States of America 1996 93 22 12433 12438
35. Braud V. M., Aldemir H., Breart B., Ferlin W. G., Expression of CD94-NKG2A inhibitory receptor is restricted to a subset of CD8 + T cells Trends in Immunology 2003 24 4 162 164
36. Pietra G., Romagnani C., Mazzarino P., Falco M., Millo E., Moretta A., Moretta L., Mingari M. C., HLA-E-restricted recognition of cytomegalovirus- derived peptides by human CD8 + cytolytic T lymphocytes Proceedings of the National Academy of Sciences of the United States of America 2003 100 19 10896 10901
37. Mazzarino P., Pietra G., Vacca P., Falco M., Colau D., Coulie P., Moretta L., Mingari M. C., Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion European Journal of Immunology 2005 35 11 3240 3247
38. Schulte D., Vogel M., Langhans B., Krmer B., Krner C., Nischalke H. D., Steinberg V., Michalk M., Berg T., Rockstroh J. K., Sauerbruch T., Spengler U., Nattermann J., The HLA-E R /HLA-E R genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon- -secreting human CD8 + T cells Journal of Infectious Diseases 2009 200 9 1397 1401
39. Thimme R., Oldach D., Chang K.-M., Steiger C., Ray S. C., Chisari F. V., Determinants of viral clearance and persistence during acute hepatitis C virus infection Journal of Experimental Medicine 2001 194 10 1395 1406
40. Reddehase M. J., Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance Nature Reviews Immunology 2002 2 11 831 844
41. Wang E. C. Y., McSharry B., Retiere C., Tomasec P., Williams S., Borysiewicz L. K., Braud V. M., Wilkinson G. W. G., UL40-mediated NK evasion during productive infection with human cytomegalovirus Proceedings of the National Academy of Sciences of the United States of America 2002 99 11 7570 7575 (Pubitemid 34568732)
42. Ulbrecht M., Martinozzi S., Grzeschik M., Hengel H., Ellwart J. W., Pla M., Weiss E. H., Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis Journal of Immunology 2000 164 10 5019 5022
43. Cerboni C., Mousavi-Jazi M., Wakiguchi H., Carbone E., Krre K., Sderstrm K., Synergistic effect of IFN- and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity European Journal of Immunology 2001 31 10 2926 2935
44. Mingari M. C., Moretta A., Moretta L., Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses Immunology Today 1998 19 4 153 156
45. Mingari M. C., Ponte M., Vitale C., Bellomo R., Moretta L., Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function Human Immunology 2000 61 1 44 50
46. Sallusto F., Geginat J., Lanzavecchia A., Central memory and effector memory T cell subsets: function, generation, and maintenance Annual Review of Immunology 2004 22 745 763
47. Marn R., Ruiz-Cabello F., Pedrinaci S., Mndez R., Jimnez P., Geraghty D. E., Garrido F., Analysis of HLA-E expression in human tumors Immunogenetics 2003 54 11 767 775 (Pubitemid 36384471)
48. Malmberg K.-J., Levitsky V., Norell H., De Matos C. T., Carlsten M., Schedvins K., Rabbani H., Moretta A., Sderstrm K., Levitskaya J., Kiessling R., IFN- protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism Journal of Clinical Investigation 2002 110 10 1515 1523
49. Wischhusen J., Friese M. A., Mittelbronn M., Meyermann R., Weller M., HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo Journal of Neuropathology and Experimental Neurology 2005 64 6 523 528
50. Bianchini M., Levy E., Zucchini C., Pinski V., Macagno C., De Sanctis P., Valvassori L., Carinci P., Mordoh J., Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa International Journal of Oncology 2006 29 1 83 94
51. Wang M.-X., Wei A., Yuan J., Trickett A., Knoops B., Murrell G. A. C., Expression and regulation of peroxiredoxin 5 in human osteoarthritis FEBS Letters 2002 531 2 359 362
52. Yuan J., Murrell G. A. C., Trickett A., Landtmeters M., Knoops B., Wang M.-X., Overexpression of antioxidant enzyme peroxiredoxin 5 protects human tendon cells against apoptosis and loss of cellular function during oxidative stress Biochimica et Biophysica Acta 2004 1693 1 37 45
53. Rohrlich P. S., Fazilleau N., Ginhoux F., Firat H., Michels F., Cochet M., Laham N., Roth M. P., Pascolo S., Nato F., Coppin H., Charneau P., Danos O., Acuto O., Ehrlich R., Kanellopoulos J., Lemonnier F. A., Direct recognition by cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function Proceedings of the National Academy of Sciences of the United States of America 2005 102 36 12855 12860
54. Romagnani C., Pietra G., Falco M., Millo E., Mazzarino P., Biassoni R., Moretta A., Moretta L., Mingari M. C., Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells Proceedings of the National Academy of Sciences of the United States of America 2002 99 17 11328 11333
55. Moretta L., Romagnani C., Pietra G., Moretta A., Mingari M. C., NK-CTLs, a novel HLA-E-restricted T-cell subset Trends in Immunology 2003 24 3 136 143
56. Hoare H. L., Sullivan L. C., Pietra G., Clements C. S., Lee E. J., Ely L. K., Beddoe T., Falco M., Kjer-Nielsen L., Reid H. H., McCluskey J., Moretta L., Rossjohn J., Brooks A. G., Structural basis for a major histocompatibility complex class Ib-restricted T cell response Nature Immunology 2006 7 3 256 264
57. Oliveira C. C., Van Veelen P. A., Querido B., De Ru A., Sluijter M., Laban S., Van Der Burg S. H., Offringa R., Van Hall T., The nonpolymorphic MHC Qa-1 b mediates CD8 + T cell surveillance of antigen-processing defects Journal of Experimental Medicine 2010 207 1 207 221